NO20003799D0 - Innkorporering av kolesterol-senkende midler i konfektdosisformer - Google Patents

Innkorporering av kolesterol-senkende midler i konfektdosisformer

Info

Publication number
NO20003799D0
NO20003799D0 NO20003799A NO20003799A NO20003799D0 NO 20003799 D0 NO20003799 D0 NO 20003799D0 NO 20003799 A NO20003799 A NO 20003799A NO 20003799 A NO20003799 A NO 20003799A NO 20003799 D0 NO20003799 D0 NO 20003799D0
Authority
NO
Norway
Prior art keywords
confectionary
cholesterol
incorporation
dosage forms
lowering agents
Prior art date
Application number
NO20003799A
Other languages
English (en)
Other versions
NO20003799L (no
NO319123B1 (no
Inventor
Gail K Buehler
Iii John D Higgins
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO20003799D0 publication Critical patent/NO20003799D0/no
Publication of NO20003799L publication Critical patent/NO20003799L/no
Publication of NO319123B1 publication Critical patent/NO319123B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Confectionery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003799A 1999-07-26 2000-07-25 Karamellkonfekt og nougatkonfekt for senkning av serumkolesterol. NO319123B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36069199A 1999-07-26 1999-07-26

Publications (3)

Publication Number Publication Date
NO20003799D0 true NO20003799D0 (no) 2000-07-25
NO20003799L NO20003799L (no) 2001-01-29
NO319123B1 NO319123B1 (no) 2005-06-20

Family

ID=23419047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003799A NO319123B1 (no) 1999-07-26 2000-07-25 Karamellkonfekt og nougatkonfekt for senkning av serumkolesterol.

Country Status (9)

Country Link
EP (1) EP1074185A1 (no)
JP (1) JP2001061442A (no)
AR (1) AR024932A1 (no)
AU (1) AU4882000A (no)
BR (1) BR0003161A (no)
CA (1) CA2314418A1 (no)
MX (1) MXPA00007268A (no)
NO (1) NO319123B1 (no)
NZ (1) NZ505933A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005280A (ko) 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
WO2005096831A1 (en) * 2004-04-01 2005-10-20 Mcneil-Ppc, Inc. Fortified confectionery products
DE102005008445A1 (de) 2005-02-24 2006-08-31 Cognis Ip Management Gmbh Zuckerhaltige Sterolfeststoffdispersionen
JP2012213339A (ja) * 2011-03-31 2012-11-08 Lotte Co Ltd 植物性ステロール配合チョコレートおよびその製造方法
FI125947B (en) 2013-07-05 2016-04-29 Ravintoraisio Oy Serum cholesterol-lowering composition
JP2016220688A (ja) * 2016-08-29 2016-12-28 株式会社ロッテ 植物性ステロール配合チョコレートおよびその製造方法
JP6578396B2 (ja) * 2018-03-02 2019-09-18 株式会社ロッテ 植物性ステロール配合チョコレートおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5860945A (ja) * 1981-10-05 1983-04-11 Asahi Denka Kogyo Kk チヨコレ−ト用又はチヨコレ−ト菓子用耐ブル−ム剤
GB8729980D0 (en) * 1987-12-23 1988-02-03 Atomic Energy Authority Uk Inhibition of nuclear-reactor coolant circuit contamination
US5514398A (en) * 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
JPH05178902A (ja) * 1991-10-29 1993-07-20 Matsutani Kagaku Kogyo Kk 難消化デキストリン
EP0828434B1 (en) * 1995-06-01 2000-02-09 Unilever N.V. Fat based food products
FI105887B (fi) * 1996-09-27 2000-10-31 Suomen Sokeri Oy Elintarvike- ja terapeuttisiin sovelluksiin käyttökelpoiset, kasvisterolia sisältävät tuotteet, menetelmä niiden valmistamiseksi ja niiden käyttö
FI108110B (fi) * 1997-06-13 2001-11-30 Danisco Finland Oy Elintarvike- ja eläinravitsemusalalla käyttökelpoinen esiseos, menetelmä sen valmistamiseksi ja sen käyttö
DE69940629D1 (no) * 1998-03-24 2009-05-07 Kao Corp

Also Published As

Publication number Publication date
BR0003161A (pt) 2001-03-13
MXPA00007268A (es) 2002-04-24
AR024932A1 (es) 2002-10-30
NZ505933A (en) 2002-11-26
JP2001061442A (ja) 2001-03-13
EP1074185A1 (en) 2001-02-07
NO20003799L (no) 2001-01-29
AU4882000A (en) 2001-02-01
CA2314418A1 (en) 2001-01-26
NO319123B1 (no) 2005-06-20

Similar Documents

Publication Publication Date Title
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
PT1221918E (pt) Administracao de drogas sub-tenon
FR2804025B1 (fr) Compositions pharmaceutiques stabilisees
NO20026001D0 (no) 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider
NO20020208L (no) Flytende sammensetninger for oral administrasjon
NO20030030D0 (no) Farmasöytiske blandinger av östrogene midler
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
EE05020B1 (et) Glburiidi ravimkoostis
NO20020185D0 (no) Formuleringer av IL-11
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
NO20020365L (no) Oligonukleotider for inhibiering av ekspresjonen av humant eg5
DE60036093D1 (de) Antagonisten des gardos-kanals
FR2802423B1 (fr) Compositions pharmaceutiques
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
NO20012976D0 (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20003799L (no) Innkorporering av kolesterol senkende midler i konfekt- dosisformer
HUP0201667A2 (en) Oral form of administration
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
NO20004816D0 (no) Ny farmasøytisk formulering
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner